The Effect of Metformin and Cinnamon on Serum Anti-Mullerian Hormone in Women Having PCOS: A Double-Blind, Randomized, Controlled Trial
Background: Polycystic ovary syndrome (PCOS) is known to be associated with insulin resistance and anti-Mullerian hormone (AMH), leading to the use of insulin-sensitizing agents (ISAs) to manage PCOS. Metformin is the most widely used ISA to treat irregular menstruation; however, the gastrointestina...
Saved in:
Main Authors: | Budi Wiweko (Author), Cynthia A Susanto (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti Müllerian Hormone as a Predictor of Metabolic Syndrome in Polycystic Ovary Syndrome
by: Budi Wiweko, et al.
Published: (2017) -
Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
by: Falbo Angela, et al.
Published: (2010) -
Evaluation of the metformin effects on Anti-Müllerian Hormone in women with polycystic ovarian syndrome: A double-blind randomized clinical trial
by: Masoud Rahmanian
Published: (2019) -
Association of anti-mullerian hormone and free androgen index level on response to clomiphene citrate in PCOS infertile women
by: Jasmine Kavitha Washington, et al.
Published: (2022) -
Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOs: A double-blind randomized clinical trial
by: Sedigheh Amooee, et al.
Published: (2013)